Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

International journal of molecular sciences - 4 Dec 2021

Ciano-Petersen Nicolás Lundahl, Cabezudo-García Pablo, Muñiz-Castrillo Sergio, Honnorat Jérôme, Serrano-Castro Pedro Jesús, Oliver-Martos Begoña

Abstract excerpt

The discovery of biomarkers in rare diseases is of paramount importance to allow a better diagnosis, improve predictions of outcomes, and prompt the development of new treatments. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a rare autoimmune disorder associated with the presence of antibodies targeting the GluN1 subunit of the NMDAR. Since it was discovered in 2007, large efforts have been made...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Neurological Disorders and Treatments
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Electroencephalography

Share to Genetic Predisposition to Disease

Share to Neuroimaging

Share to Prognosis

Share to Receptors, N-Methyl-D-Aspartate

Source

Open in PubMed Open full text

Identifiers

PMID: 34884930
DOI: 10.3390/ijms222313127
PMCID: PMC8658717

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.PMID 34884930Read ↗

Autoimmune EncephalitisSemantic proximity Read ↗

Anti-NMDA Receptor Encephalitis Following SARS-CoV-2 Infection: A Systematic Review and Pooled Case SeriesSemantic proximity Read ↗

Clinical analysis of MOG antibody-associated disease overlapped with anti-NMDA receptor encephalitis: a long-term retrospective studySemantic proximity Read ↗

All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin classSemantic proximity Read ↗

Multi-proteomic Analysis Revealed Distinct Protein Profiles in Cerebrospinal Fluid of Patients Between Anti-NMDAR Encephalitis NORSE and Cryptogenic NORSESemantic proximity Read ↗

Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis.Semantic proximity Read ↗

Decreased inflammatory cytokine production of antigen-specific CD4<sup>+</sup>T cells in NMDA receptor encephalitisSemantic proximity Read ↗

Immunoregulatory programs in anti‐N‐methyl‐D‐aspartate receptor encephalitis identified by single‐cell multi‐omics analysisSemantic proximity Read ↗

Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.Semantic proximity Read ↗

Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study.Semantic proximity Read ↗

A Novel Simple ImmunoAssay for Quantification of Blood Anti-NMDAR1 AutoantibodiesSemantic proximity Read ↗

NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.